Several Critical Principals Of Effective Key Account Management

Not all clients are created equally and pharmaceutical companies realise that they may not treat them all with a similar approach, due to the competitive nature of this environment. This can be due to their position of dominance within the market, the volume of transactions or any other strategic elements making them of particular interest to the company. Key account management strategies must be created and then disseminated to sales and marketing people to enable relationships to be cemented.

Client management can be a complicated undertaking, involving public relations issues, politics and positioning just as much as it can be about the provision of services. Executives must decide whether an account is key or not, but interaction and daily implementation falls to the sales and marketing team, with the pharmaceutical consulting firm providing critical direction.

Attention to fine detail is required here, like in no other environment, once an account has been classified as of strategic importance. The key accounts in turn will value the relationship with the pharmaceutical company more highly, especially if they are predisposed to a more interactive approach. The goal must be to facilitate the work of the key client and to ensure that the pharmaceutical company’s products are more widely available, at competitive rates and the subject of enhanced information and education.

Key account management can be divided into five areas:

Firstly, all parties must fully understand the level of the agreement. Once this is cemented, it must be communicated throughout the company structure, ensuring the correct level of response. A level of formality should be achieved and maintained, incorporating reviews and communication as appropriate, but the ultimate goal should be to strengthen the bond between them.

Key account management involves the building of trust and two-way commitment. The client must feel that it is in a comfort zone when dealing with the pharmaceutical company and will therefore not have to invest effort or money in trying to control certain activities associated with the program. This new level of efficiency prompts even more commitment. This interaction may appear complex and daunting, but pharmaceutical consultants are well versed in such strategies.

When it comes to the sales and marketing team, the customer accounts must be fully reviewed, its content absorbed and potential understood. In truly key accounts, the pharmaceutical company will help the client through the dissemination of important trends and industry data. These accounts are always dynamic and a sales and marketing team must be on the ball and trained well.

Few relationships of this kind run smoothly and without issues from time to time. While conflict should be avoided at all costs as it could disturb the two-way commitment to the program, it can also be constructive in certain situations, leading to new paths and the exploration of different options, potentially cementing a relationship still further.

Key account management requires a continuous review of satisfaction. This will in turn help to reveal some potential stumbling blocks in the future and allow for the swift resolution of any issues or challenges as and when they arise.

These five concepts are fundamental to the pharma consulting approach.

Alan Gillies is the Managing Director of L2L Consulting, specialising in enabling pharmaceutical companies to achieve new heights of productivity and performance, throughout all levels of management and revenue generating activities.